LeonaBio (LONA) Current Leases (2020 - 2026)
LeonaBio (LONA) posted quarterly Current Leases of $478000.0 for Q1 2026, up 12.21% year-over-year from $426000.0 in Q1 2025, and up 2.8% quarter-over-quarter from $465000.0 in Q4 2025.
LeonaBio (LONA) Current Leases (2020 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Current Leases for 7 consecutive years, with $478000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 12.21% year-over-year to $478000.0; the TTM figure through Mar 2026 stood at $478000.0 (up 12.21% YoY), while the FY2025 annual figure was $465000.0, up 12.32% from the prior year.
- Current Leases grew to $478000.0 in Q1 2026 per LONA's latest filing, from $465000.0 in the prior quarter.
- Across five years, Current Leases topped out at $478000.0 in Q1 2026 and bottomed at $297000.0 in Q1 2022.
- Historically, Current Leases has averaged $382529.4 across 5 years, with a median of $380000.0 in 2024.
- Annual changes were most pronounced in 2022 — Current Leases surged 48.5% — and 2025, when it grew 12.11%.
- LeonaBio's Current Leases stood at $326000.0 in 2022, then increased by 12.88% to $368000.0 in 2023, then increased by 12.5% to $414000.0 in 2024, then advanced by 12.32% to $465000.0 in 2025, then climbed by 2.8% to $478000.0 in 2026.
- Business Quant data shows LONA's Current Leases at $478000.0 in Q1 2026, $465000.0 in Q4 2025, and $452000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | 491,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 478,000.00 |
| Dec 31, 2025 | 465,000.00 |
| Sep 30, 2025 | 452,000.00 |
| Jun 30, 2025 | 439,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 414,000.00 |
| Sep 30, 2024 | 402,000.00 |
| Jun 30, 2024 | 391,000.00 |
| Mar 31, 2024 | 380,000.00 |
| Dec 31, 2023 | 368,000.00 |
| Sep 30, 2023 | 358,000.00 |
| Jun 30, 2023 | 347,000.00 |
| Mar 31, 2023 | 337,000.00 |
| Dec 31, 2022 | 326,000.00 |
| Sep 30, 2022 | 316,000.00 |
| Jun 30, 2022 | 307,000.00 |
| Mar 31, 2022 | 297,000.00 |
| Dec 31, 2021 | 288,000.00 |
| Sep 30, 2021 | 279,000.00 |
| Jun 30, 2021 | 263,000.00 |